Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price t

Cryoport, Inc., rated BUY, is up 82% YTD, driven by robust cell and gene therapy (CGT) commercializa

CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflect

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price t

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price targ

CryoPort NASDAQ: CYRX reported second-quarter 2026 revenue of $49 million and said it reached positi

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.2 per share in line with the Zacks Consen

CryoPort (NASDAQ:CYRX) affirms FY2026 sales outlook from $192.000 million-$196.000 million to $192.0

CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.20) per share which missed the analyst conse

Second quarter revenue grew 8% year-over-year to $49.0 million Life Sciences Services revenue increa

BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target

NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Co

IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Service

IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Service

Craig-Hallum analyst Matthew Hewitt maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the pr

Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the pri

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price t

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price targ

Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus E

First quarter revenue grew 16% year-over-year to $47.8 million Commercial cell and gene therapy (CGT

NASHVILLE, Tenn., April 20, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "C

Cryoport receives a buy rating with a $9.1 price target, implying 17% upside by FY 2026. CYRX demons

CryoPort, Inc. (NASDAQ: CYRX - Get Free Report) has received a consensus recommendation of "Moderate

Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/down

Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus E

FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance Life Scienc

NASHVILLE, Tenn., Feb. 17, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Co

Self-Sustaining Fusion® 800 Series  Cryogenic Freezer Delivers High-Capacity Storage, Flexibility, a

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

  Monday's session saw 175 companies set new 52-week lows.

  On Thursday, 128 companies set new 52-week lows.

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

  During Tuesday's trading, 188 companies set new 52-week lows.